Cognex Corp (CGNX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CGNX SEC filings page.
Cognex Corp (CGNX) reported $1.1B in revenue over the twelve months to Jul 5, 2026, up 17.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cognex’s 2025 recovery was powered more by operating cost absorption and cash conversion than by gross-margin expansion.
Revenue recovered to$994M in FY2025 while gross margin slipped to66.9% , so the recovery did not come from a higher gross-profit rate. Operating margin nevertheless reached16.4% as SG&A fell to$364M , pointing to below-gross-profit cost absorption.
Operating cash flow reached
Net margin stayed near
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cognex Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cognex Corp has an operating margin of 16.4%, meaning the company retains $16 of operating profit per $100 of revenue. This strong profitability earns a score of 74/100, reflecting efficient cost management and pricing power. This is up from 12.6% the prior year.
Cognex Corp's revenue grew 8.7% year-over-year to $994.4M, a solid pace of expansion. This earns a growth score of 63/100.
Cognex Corp carries a low D/E ratio of 0.35, meaning only $0.35 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 67/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.80, Cognex Corp holds $3.80 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 86/100.
Cognex Corp converts 23.8% of revenue into free cash flow ($236.8M). This strong cash generation earns a score of 84/100.
Cognex Corp's ROE of 7.7% shows moderate profitability relative to equity, earning a score of 59/100. This is up from 7.0% the prior year.
Cognex Corp scores 13.85, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($10.9B) relative to total liabilities ($524.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cognex Corp passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Cognex Corp generates $2.15 in operating cash flow ($245.5M OCF vs $114.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Cognex Corp generated $291.3M in revenue in Q3 2026. This represents an increase of 5.2% from the same quarter a year earlier. Against the prior quarter it is up 8.5%.
Cognex Corp's EBITDA was $92.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 41.5% from the same quarter a year earlier. Against the prior quarter it is up 37.7%.
Cognex Corp reported $72.8M in net income in Q3 2026. This represents an increase of 311.9% from the same quarter a year earlier. Against the prior quarter it is up 40.7%.
Cognex Corp earned $0.43 per diluted share (EPS) in Q3 2026. This represents an increase of 330.0% from the same quarter a year earlier. Against the prior quarter it is up 38.7%.
Cash & Balance Sheet
Cognex Corp generated $67.6M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 21.4% from the same quarter a year earlier. Against the prior quarter it is up 59.7%.
Cognex Corp held $302.5M in cash as of Q3 2026; long-term debt is not reported for that period.
Cognex Corp paid $0.09 per share in dividends in Q3 2026. This represents an increase of 6.3% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Cognex Corp's gross margin was 70.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.
Cognex Corp's operating margin was 29.4% in Q3 2026, reflecting core business profitability. This is up 8.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.1 percentage points.
Cognex Corp's net profit margin was 25.0% in Q3 2026, showing the share of revenue converted to profit. This is up 18.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.7 percentage points.
Cognex Corp's ROE was 4.5% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Capital Allocation
Cognex Corp invested $32.4M in research and development in Q3 2026. This represents a decrease of 7.7% from the same quarter a year earlier. Against the prior quarter it is down 12.5%.
Cognex Corp spent $6.2M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 74.0% from the same quarter a year earlier. Against the prior quarter it is down 93.7%.
Cognex Corp invested $1.5M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 5.5% from the same quarter a year earlier. Against the prior quarter it is down 44.4%.
CGNX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $291.3M+5.2% | $268.4M+7.8% | $252.3M+9.9% | $276.9M+18.0% | $249.1M+4.1% | $216.0M+2.5% | $229.7M+16.4% | $234.7M-3.2% |
| Cost of Revenue | $85.5M-4.6% | $77.5M-4.6% | $86.4M+20.3% | $89.6M+18.9% | $81.2M+11.7% | $71.7M+4.1% | $71.8M+31.9% | $75.3M+19.9% |
| Gross Profit | $205.8M+9.9% | $190.9M+13.7% | $165.9M+5.1% | $187.3M+17.5% | $167.9M+0.8% | $144.3M+1.7% | $157.9M+10.6% | $159.4M-11.3% |
| R&D Expenses | $32.4M-7.7% | $37.0M+11.9% | $36.1M+10.8% | $35.1M-0.4% | $33.1M-5.3% | $34.7M-6.4% | $32.5M-0.1% | $35.2M+4.8% |
| SG&A Expenses | $87.9M-7.0% | $94.0M+3.0% | $94.6M+0.1% | $94.4M+2.0% | $91.3M-2.0% | $83.5M-7.9% | $94.5M+14.8% | $92.6M+11.0% |
| Operating Income | $85.5M+48.0% | $59.9M+37.9% | $35.3M+14.4% | $57.8M+83.0% | $43.4M+12.9% | $26.1M+83.7% | $30.8M+0.7% | $31.6M-51.6% |
| EBITDA | $92.4M+41.5% | $67.1M+30.5% | $42.6M+10.1% | $65.3M+61.7% | $51.4M+10.9% | $34.0M+52.6% | $38.7M+8.2% | $40.4M-42.4% |
| Income Tax | $16.5M-63.4% | $10.1M+33.1% | $11.4M+53.1% | $45.2M+549.0% | $7.6M+41.0% | $4.2M-24.3% | $7.5M-7.8% | $7.0M-32.4% |
| Net Income | $72.8M+311.9% | $51.7M+27.6% | $32.7M+15.2% | $17.7M-40.3% | $40.5M+11.9% | $23.6M+96.3% | $28.3M+49.9% | $29.6M-48.5% |
| EPS (Basic) | $0.43+290.9% | $0.31+29.2% | $0.19+11.8% | $0.11-35.3% | $0.24+14.3% | $0.14+100.0% | $0.17+54.5% | $0.17-48.5% |
| EPS (Diluted) | $0.43+330.0% | $0.31+29.2% | $0.20+17.6% | $0.10-41.2% | $0.24+14.3% | $0.14+100.0% | $0.17+54.5% | $0.17-48.5% |
| Diluted Shares (Avg) | 170M+0.4% | 168M-0.1% | N/A | 169M-2.0% | 169M-2.4% | 170M-1.3% | N/A | 173M-0.5% |
Not reported in any period shown, so not listed: Interest Expense.
CGNX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B+8.8% | $2.0B+0.1% | $2.0B+1.2% | $2.0B-2.9% | $2.0B0.0% | $1.9B-4.0% | $2.0B+0.1% | $2.1B+3.3% |
| Current Assets | $849.9M+26.7% | $690.3M+10.3% | $697.2M+13.7% | $670.9M-0.2% | $625.7M-8.1% | $577.7M-12.7% | $613.4M-27.6% | $672.1M-6.4% |
| Cash & Equivalents | $302.5M+23.0% | $237.3M+32.4% | $262.9M+41.3% | $245.9M+24.8% | $179.3M+1.5% | $143.7M+3.5% | $186.1M-52.9% | $197.1M+11.0% |
| Short-Term Investments | $101.8M+87.3% | $59.4M+21.5% | $74.0M+23.5% | $54.4M-40.1% | $48.9M-56.5% | $56.7M-59.3% | $60.0M-48.8% | $90.8M-52.6% |
| Inventory | $142.8M-0.6% | $135.5M-6.2% | $137.9M-12.5% | $143.7M-7.5% | $144.6M-8.1% | $152.1M-11.0% | $157.5M+17.7% | $155.3M+23.0% |
| Accounts Receivable | $216.2M+39.9% | $170.7M-7.2% | $146.7M+2.3% | $154.6M-2.1% | $183.9M+15.5% | $161.2M+16.3% | $143.4M+9.8% | $158.0M+6.8% |
| Long-Term Investments | $350.6M+16.9% | $325.2M+0.3% | $305.3M-10.4% | $300.1M-6.0% | $324.3M+21.8% | $312.3M+12.2% | $340.9M+2.4% | $319.3M-31.1% |
| Goodwill | $381.4M-2.7% | $382.8M-3.7% | $386.3M+0.3% | $392.1M+0.1% | $397.4M+4.3% | $389.9M+1.0% | $384.9M+59.7% | $391.7M+62.1% |
| Total Liabilities | $549.1M+7.0% | $526.6M+5.9% | $524.7M+10.4% | $513.1M+3.4% | $497.5M0.0% | $486.9M-7.1% | $475.3M-5.2% | $496.2M-4.1% |
| Current Liabilities | $216.0M+27.6% | $189.5M-0.5% | $183.6M+8.4% | $169.3M-0.9% | $190.4M+12.8% | $184.0M-2.2% | $169.4M-0.2% | $170.7M-5.4% |
| Non-Current Liabilities | $333.1M-3.1% | $337.2M+9.8% | $341.1M+11.5% | $343.8M+5.6% | $307.0M-6.6% | $302.9M-9.8% | $306.0M-7.7% | $325.5M-3.5% |
| Total Equity | $1.6B+9.4% | $1.5B-1.8% | $1.5B-1.7% | $1.5B-4.9% | $1.5B0.0% | $1.4B-2.9% | $1.5B+1.9% | $1.6B+5.8% |
| Retained Earnings | $397.1M-3.7% | $344.4M-20.5% | $406.4M-18.6% | $412.3M-21.9% | $433.0M-15.9% | $405.9M-19.2% | $499.3M-6.6% | $527.9M-1.9% |
Not reported in any period shown, so not listed: Long-Term Debt.
CGNX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $69.2M-21.0% | $45.1M+5.8% | $74.9M+45.7% | $87.5M+55.5% | $42.6M+53.5% | $40.5M+196.9% | $51.4M+25.3% | $56.3M+88.5% |
| Depreciation & Amortization | $6.9M-8.7% | $7.2M-9.6% | $7.3M-6.8% | $7.5M-14.6% | $8.0M+1.0% | $7.9M-2.0% | $7.9M+53.4% | $8.8M+78.7% |
| Stock-Based Compensation | $11.2M-9.7% | $11.9M-2.9% | N/A | $12.4M-5.2% | $12.3M-5.2% | $9.9M-25.3% | N/A | $13.1M+4.2% |
| Capital Expenditures | $1.5M+5.5% | $2.8M+25.7% | $2.6M+25.2% | $1.5M-67.0% | $2.2M-51.4% | $2.5M-38.4% | $2.1M-64.6% | $4.4M-6.4% |
| Free Cash Flow | $67.6M-21.4% | $42.3M+4.7% | $72.3M+46.6% | $86.0M+65.9% | $40.4M+73.9% | $38.0M+296.6% | $49.3M+40.3% | $51.9M+106.3% |
| Investing Cash Flow | -$70.5M-480.9% | $791K+119.9% | -$19.6M-981.3% | $18.5M+167.5% | -$4.0M-111.3% | $33.1M+167.5% | $2.2M-98.9% | -$27.4M-258.6% |
| Financing Cash Flow | $66.8M+277.7% | -$68.9M-419.8% | -$37.5M+32.7% | -$37.6M-147.8% | -$13.3M+40.9% | -$118.4M-371.8% | -$55.8M-154.5% | -$15.2M+51.6% |
| Dividends Paid | $14.3M+6.1% | $14.2M+5.7% | $14.2M+3.6% | $13.4M+4.5% | $13.4M+4.4% | $13.6M+5.1% | $13.7M+13.8% | $12.9M+6.6% |
| Share Buybacks | $6.2M-74.0% | $99.0M | $25.0M-42.2% | $24.0M+505.8% | $0-100.0% | $102.2M+994.7% | $43.2M+312.8% | $4.0M-84.1% |
CGNX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.7%+3.0pp | 71.1%+3.7pp | 65.8%-3.0pp | 67.6%-0.3pp | 67.4%-2.2pp | 66.8%-0.5pp | 68.7%-3.7pp | 67.9%-6.2pp |
| Operating Margin | 29.4%+8.5pp | 22.3%+4.9pp | 14.0%+0.6pp | 20.9%+7.4pp | 17.4%+1.4pp | 12.1%+5.3pp | 13.4%-2.1pp | 13.5%-13.4pp |
| Net Margin | 25.0%+18.6pp | 19.3%+3.0pp | 12.9%+0.6pp | 6.4%-6.2pp | 16.3%+1.1pp | 10.9%+5.2pp | 12.3%+2.7pp | 12.6%-11.1pp |
| Return on Equity | 4.5%+3.3pp | 3.5%+0.8pp | 2.2%+0.3pp | 1.2%-0.7pp | 2.7%+0.3pp | 1.6%+0.8pp | 1.9%+0.6pp | 1.9%-2.0pp |
| Return on Assets | 3.3%+2.5pp | 2.6%+0.6pp | 1.6%+0.2pp | 0.9%-0.5pp | 2.0%+0.2pp | 1.2%+0.6pp | 1.4%+0.5pp | 1.4%-1.4pp |
| Current Ratio | 3.930.0x | 3.64+0.4x | 3.80+0.2x | 3.960.0x | 3.29-0.7x | 3.14-0.4x | 3.62-1.4x | 3.940.0x |
| Debt-to-Equity | 0.340.0x | 0.360.0x | 0.350.0x | 0.340.0x | 0.330.0x | 0.340.0x | 0.310.0x | 0.320.0x |
| Asset Turnover | 0.130.0x | 0.130.0x | 0.130.0x | 0.140.0x | 0.120.0x | 0.110.0x | 0.120.0x | 0.110.0x |
| FCF Margin | 23.2%-7.8pp | 15.8%-0.5pp | 28.6%+7.2pp | 31.1%+9.0pp | 16.2%+6.5pp | 17.6%+13.0pp | 21.5%+3.7pp | 22.1%+11.7pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cognex Corp CGNX | FY2025 | $994.4M | $114.4M | 11.5% | $10.9B | 72/100 |
| MKS Inc. MKSI | FY2025 | $3.9B | $295.0M | 7.5% | $18.3B | 44/100 |
| Vontier Corporation VNT | FY2025 | $3.1B | $406.1M | 13.2% | $4.3B | 57/100 |
| Badger Meter, Inc. BMI | FY2025 | $916.7M | $141.6M | 15.4% | $3.7B | 80/100 |
| ESCO Technologies, Inc. ESE | FY2025 | $1.1B | $299.2M | 27.3% | $7.0B | 69/100 |
| Itron Inc ITRI | FY2025 | $2.4B | $301.1M | 12.7% | $3.8B | 63/100 |
Where Cognex Corp Ranks
Frequently Asked Questions
What is Cognex Corp's annual revenue?
Cognex Corp (CGNX) reported $994.4M in total revenue for fiscal year 2025. This represents a 8.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cognex Corp's revenue growing?
Cognex Corp (CGNX) revenue grew by 8.7% year-over-year, from $914.5M to $994.4M in fiscal year 2025.
Is Cognex Corp profitable?
Yes, Cognex Corp (CGNX) reported a net income of $114.4M in fiscal year 2025, with a net profit margin of 11.5%.
What is Cognex Corp's EBITDA?
Cognex Corp (CGNX) had EBITDA of $193.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Cognex Corp's gross margin?
Cognex Corp (CGNX) had a gross margin of 66.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cognex Corp's operating margin?
Cognex Corp (CGNX) had an operating margin of 16.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cognex Corp's net profit margin?
Cognex Corp (CGNX) had a net profit margin of 11.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Cognex Corp pay dividends?
Yes, Cognex Corp (CGNX) paid $0.33 per share in dividends during fiscal year 2025.
What is Cognex Corp's return on equity (ROE)?
Cognex Corp (CGNX) has a return on equity of 7.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cognex Corp's free cash flow?
Cognex Corp (CGNX) generated $236.8M in free cash flow during fiscal year 2025. This represents a 76.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cognex Corp's operating cash flow?
Cognex Corp (CGNX) generated $245.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cognex Corp's total assets?
Cognex Corp (CGNX) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cognex Corp's capital expenditures?
Cognex Corp (CGNX) invested $8.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Cognex Corp spend on research and development?
Cognex Corp (CGNX) invested $139.0M in research and development during fiscal year 2025.
What is Cognex Corp's current ratio?
Cognex Corp (CGNX) had a current ratio of 3.80 as of fiscal year 2025, which is generally considered healthy.
What is Cognex Corp's debt-to-equity ratio?
Cognex Corp (CGNX) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cognex Corp's return on assets (ROA)?
Cognex Corp (CGNX) had a return on assets of 5.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cognex Corp's P/E ratio?
Cognex Corp (CGNX) trades at 62.5x earnings, its market capitalization divided by net income of $174.8M net income, trailing 12 months to July 5, 2026. The market capitalization is $10.9B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cognex Corp's price-to-sales ratio?
Cognex Corp (CGNX) trades at 10.0x sales, its market capitalization divided by revenue of $1.1B revenue, trailing 12 months to July 5, 2026. The market capitalization is $10.9B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cognex Corp's Altman Z-Score?
Cognex Corp (CGNX) has an Altman Z-Score of 13.85, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cognex Corp's Piotroski F-Score?
Cognex Corp (CGNX) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cognex Corp's earnings high quality?
Cognex Corp (CGNX) has an earnings quality ratio of 2.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Cognex Corp?
Cognex Corp (CGNX) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.